Selected article for: "molecular testing and rapid serological test"

Author: Angelo Virgilio Paradiso; Simona De Summa; Daniela Loconsole; Vito Procacci; Anna Sallustio; Francesca Centrone; Nicola Silvestris; Vito Cafagna; Giuseppe De Palma; Antonio Tufaro; Vito Garrisi; Maria Chironna
Title: Clinical meanings of rapid serological assay in patients tested for SARS-Co2 RT-PCR
  • Document date: 2020_4_6
  • ID: ilxd0ih9_24
    Snippet: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.04.03.20052183 doi: medRxiv preprint institutional consecutive cohort of patients who were tested with both assays each in a single qualified laboratory. The design of our study allowed us to specifically analyze two aspects of the open issue: the concordance of the rapid serological test with standard molecular testing; the trend of immunog.....
    Document: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.04.03.20052183 doi: medRxiv preprint institutional consecutive cohort of patients who were tested with both assays each in a single qualified laboratory. The design of our study allowed us to specifically analyze two aspects of the open issue: the concordance of the rapid serological test with standard molecular testing; the trend of immunoglobulinsIgG/IgMexpression with respect to the onset of clinical symptoms.

    Search related documents:
    Co phrase search for related documents
    • assay test and clinical symptom onset: 1, 2
    • assay test and clinical symptom onset respect: 1
    • assay test and molecular testing: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • assay test and qualified laboratory: 1
    • assay test and serological test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • assay test and standard molecular testing: 1
    • assay test and study design: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical symptom and consecutive cohort: 1
    • clinical symptom and serological test: 1
    • clinical symptom and study design: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • clinical symptom onset and study design: 1, 2
    • consecutive cohort and patient consecutive cohort: 1, 2, 3, 4, 5
    • consecutive cohort and study design: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • molecular testing and serological test: 1, 2, 3, 4, 5, 6, 7
    • molecular testing and standard molecular testing: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • molecular testing and standard molecular testing serological test: 1
    • molecular testing and study design: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • serological test and standard molecular testing: 1, 2
    • serological test and standard molecular testing serological test: 1